Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature

Monikaben Padariya1, Alicja Sznarkowska1, Sachin Kote1

  • 1International Centre for Cancer Vaccine Science, University of Gdansk, ul. Kładki 24, 80-822 Gdansk, Poland.

Biomolecules
|April 30, 2021
PubMed

Insights

Interferon-related DNA damage resistant signature (IRDS) genes promote cancer resistance to therapy. Targeting these IRDS genes may resensitize tumors, improving anti-cancer treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Interferon-related DNA damage resistant signature (IRDS) genes are upregulated in cancers, conferring resistance to chemotherapy and radiotherapy.
  • These genes are part of the larger interferon-stimulated genes (ISGs) family and are influenced by viral infections.

Purpose of the Study:

  • To review the role of IRDS genes in cancer therapy resistance.
  • To explore strategies for targeting IRDS genes to enhance treatment sensitivity.
  • To identify upstream regulators and functional interactions of IRDS genes.

Main Methods:

  • Literature review of IRDS genes, their regulation by interferons (IFNs), and their association with biological pathways.
  • Analysis of viral effects on IRDS genes and strategies to suppress them.
  • Identification of pharmacophore models for IRDS protein interactions with biomolecules.

Main Results:

  • IRDS genes, including STAT1, IRF7, OAS family, and BST2, contribute to chemo- and radioresistance.
  • Specific IRDS genes are frequently associated with pathways involving IFIT1/3, IFITM1, ISG15, MX1/2, and OAS1/3/L.
  • Pharmacophore models reveal interactions of IRDS proteins with DNA, RNA, GDP, and NADP+, with Lysine commonly involved in ATP binding.

Conclusions:

  • Targeting IRDS genes represents a promising strategy to overcome cancer therapy resistance.
  • Understanding IRDS gene function and interactions can lead to novel therapeutic approaches for cancer treatment.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.2K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.5K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.2K